Heart Disease Insurance Comprehensive Study by Distribution Channel (Online Insurance Service, Offline Insurance Service), Duration (Life Insurance, Term Insurance), Features (Diagnosis/Procedure, Medicines Coverage, Surgery Coverage, Others), End User (Children, Adult) Players and Region - Global Market Outlook to 2026

Heart Disease Insurance Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Heart Disease Insurance Market?

Heart disease insurance protects against the heart health-related contingencies in terms of expenses required at the time of treatment. The insurance plan helps in planning the contingencies and covers the various type of conditions under heart disease. It is good to maintain enough healthcare coverage with an insurance policy for easy payment to cardiologists and physicians. It can be available on a long-term and short-term basis and its premium and coverage vary on adult or child heart disease insurance policy.

The market study is being classified and major geographies with country level break-up.

Aviva plc (United Kingdom), Legal & General Group plc (United Kingdom), Aflac Inc (United States), Axa S.A. (France), Aegon Life Insurance (India), Allianz SE (Germany), Gobeille v. Liberty Mutual Insurance (United States), MetLife, Inc. (United States) and Star Health Insurance (India) are some of the key players profiled in the study.

Segment Analysis
Analyst at AMA have segmented the market study of Global Heart Disease Insurance market by Type, Application and Region.

On the basis of geography, the market of Heart Disease Insurance has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Growing Number of Heart Disease Patients
  • Need for Getting Secured Against the Huge Expenses at the Time of Uncertain Diseases

Market Trend
  • Emerging Number of Heart Disease Insurance Plans and Policies

Restraints
  • High-Cost Premium Involved in Heart Disease Insurance
  • Lack of Awareness about Heart Disease Insurance Policies Rural Areas of the World and Problems with the Affordability

Opportunities
  • Surging Demand for Heart Disease Insurance Among Developing Countries
  • Raising Awareness about teh Heart Disease Insurance Plans through Marketing

Challenges
  • Regulatory Guidelines Associated with Heart Disease Insurance


On 2nd November 2020, Aegon Life Insurance has announced the launch of ‘Life + 36 critical illness Insurance’ on Flipkart at the starting premium of just Rs. 153 for a life cover of Rs 1 lakh plus Critical Illness cover of Rs.10,000. This means that the policyholder gets the benefit of life protection along with a lump sum pay-out on the diagnosis of any of the 36 critical illnesses.


Key Target Audience
Heart Disease Insurance Providers, Heart Disease Insurance Industry Association, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others

Report Objectives / Segmentation Covered

By Distribution Channel
  • Online Insurance Service
  • Offline Insurance Service

By Duration
  • Life Insurance
  • Term Insurance

By Features
  • Diagnosis/Procedure
  • Medicines Coverage
  • Surgery Coverage
  • Others

By End User
  • Children
  • Adult

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Heart Disease Patients
      • 3.2.2. Need for Getting Secured Against the Huge Expenses at the Time of Uncertain Diseases
    • 3.3. Market Challenges
      • 3.3.1. Regulatory Guidelines Associated with Heart Disease Insurance
    • 3.4. Market Trends
      • 3.4.1. Emerging Number of Heart Disease Insurance Plans and Policies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Heart Disease Insurance, by Distribution Channel, Duration, Features, End User and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Heart Disease Insurance (Value)
      • 5.2.1. Global Heart Disease Insurance by: Distribution Channel (Value)
        • 5.2.1.1. Online Insurance Service
        • 5.2.1.2. Offline Insurance Service
      • 5.2.2. Global Heart Disease Insurance by: Duration (Value)
        • 5.2.2.1. Life Insurance
        • 5.2.2.2. Term Insurance
      • 5.2.3. Global Heart Disease Insurance by: Features (Value)
        • 5.2.3.1. Diagnosis/Procedure
        • 5.2.3.2. Medicines Coverage
        • 5.2.3.3. Surgery Coverage
        • 5.2.3.4. Others
      • 5.2.4. Global Heart Disease Insurance by: End User (Value)
        • 5.2.4.1. Children
        • 5.2.4.2. Adult
      • 5.2.5. Global Heart Disease Insurance Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Heart Disease Insurance: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Aviva plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Legal & General Group plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Aflac Inc (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Axa S.A. (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aegon Life Insurance (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Allianz SE (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Gobeille v. Liberty Mutual Insurance (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. MetLife, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Star Health Insurance (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Heart Disease Insurance Sale, by Distribution Channel, Duration, Features, End User and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Heart Disease Insurance (Value)
      • 7.2.1. Global Heart Disease Insurance by: Distribution Channel (Value)
        • 7.2.1.1. Online Insurance Service
        • 7.2.1.2. Offline Insurance Service
      • 7.2.2. Global Heart Disease Insurance by: Duration (Value)
        • 7.2.2.1. Life Insurance
        • 7.2.2.2. Term Insurance
      • 7.2.3. Global Heart Disease Insurance by: Features (Value)
        • 7.2.3.1. Diagnosis/Procedure
        • 7.2.3.2. Medicines Coverage
        • 7.2.3.3. Surgery Coverage
        • 7.2.3.4. Others
      • 7.2.4. Global Heart Disease Insurance by: End User (Value)
        • 7.2.4.1. Children
        • 7.2.4.2. Adult
      • 7.2.5. Global Heart Disease Insurance Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Heart Disease Insurance: by Distribution Channel(USD Million)
  • Table 2. Heart Disease Insurance Online Insurance Service , by Region USD Million (2015-2020)
  • Table 3. Heart Disease Insurance Offline Insurance Service , by Region USD Million (2015-2020)
  • Table 4. Heart Disease Insurance: by Duration(USD Million)
  • Table 5. Heart Disease Insurance Life Insurance , by Region USD Million (2015-2020)
  • Table 6. Heart Disease Insurance Term Insurance , by Region USD Million (2015-2020)
  • Table 7. Heart Disease Insurance: by Features(USD Million)
  • Table 8. Heart Disease Insurance Diagnosis/Procedure , by Region USD Million (2015-2020)
  • Table 9. Heart Disease Insurance Medicines Coverage , by Region USD Million (2015-2020)
  • Table 10. Heart Disease Insurance Surgery Coverage , by Region USD Million (2015-2020)
  • Table 11. Heart Disease Insurance Others , by Region USD Million (2015-2020)
  • Table 12. Heart Disease Insurance: by End User(USD Million)
  • Table 13. Heart Disease Insurance Children , by Region USD Million (2015-2020)
  • Table 14. Heart Disease Insurance Adult , by Region USD Million (2015-2020)
  • Table 15. South America Heart Disease Insurance, by Country USD Million (2015-2020)
  • Table 16. South America Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 17. South America Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 18. South America Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 19. South America Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 20. Brazil Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 21. Brazil Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 22. Brazil Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 23. Brazil Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 24. Argentina Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 25. Argentina Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 26. Argentina Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 27. Argentina Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 28. Rest of South America Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 29. Rest of South America Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 30. Rest of South America Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 31. Rest of South America Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 32. Asia Pacific Heart Disease Insurance, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 34. Asia Pacific Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 35. Asia Pacific Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 36. Asia Pacific Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 37. China Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 38. China Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 39. China Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 40. China Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 41. Japan Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 42. Japan Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 43. Japan Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 44. Japan Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 45. India Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 46. India Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 47. India Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 48. India Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 49. South Korea Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 50. South Korea Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 51. South Korea Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 52. South Korea Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 53. Taiwan Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 54. Taiwan Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 55. Taiwan Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 56. Taiwan Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 57. Australia Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 58. Australia Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 59. Australia Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 60. Australia Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 65. Europe Heart Disease Insurance, by Country USD Million (2015-2020)
  • Table 66. Europe Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 67. Europe Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 68. Europe Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 69. Europe Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 70. Germany Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 71. Germany Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 72. Germany Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 73. Germany Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 74. France Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 75. France Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 76. France Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 77. France Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 78. Italy Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 79. Italy Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 80. Italy Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 81. Italy Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 82. United Kingdom Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 83. United Kingdom Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 84. United Kingdom Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 85. United Kingdom Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 86. Netherlands Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 87. Netherlands Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 88. Netherlands Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 89. Netherlands Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 90. Rest of Europe Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 91. Rest of Europe Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 92. Rest of Europe Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 93. Rest of Europe Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 94. MEA Heart Disease Insurance, by Country USD Million (2015-2020)
  • Table 95. MEA Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 96. MEA Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 97. MEA Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 98. MEA Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 99. Middle East Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 100. Middle East Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 101. Middle East Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 102. Middle East Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 103. Africa Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 104. Africa Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 105. Africa Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 106. Africa Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 107. North America Heart Disease Insurance, by Country USD Million (2015-2020)
  • Table 108. North America Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 109. North America Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 110. North America Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 111. North America Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 112. United States Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 113. United States Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 114. United States Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 115. United States Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 116. Canada Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 117. Canada Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 118. Canada Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 119. Canada Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 120. Mexico Heart Disease Insurance, by Distribution Channel USD Million (2015-2020)
  • Table 121. Mexico Heart Disease Insurance, by Duration USD Million (2015-2020)
  • Table 122. Mexico Heart Disease Insurance, by Features USD Million (2015-2020)
  • Table 123. Mexico Heart Disease Insurance, by End User USD Million (2015-2020)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Heart Disease Insurance: by Distribution Channel(USD Million)
  • Table 134. Heart Disease Insurance Online Insurance Service , by Region USD Million (2021-2026)
  • Table 135. Heart Disease Insurance Offline Insurance Service , by Region USD Million (2021-2026)
  • Table 136. Heart Disease Insurance: by Duration(USD Million)
  • Table 137. Heart Disease Insurance Life Insurance , by Region USD Million (2021-2026)
  • Table 138. Heart Disease Insurance Term Insurance , by Region USD Million (2021-2026)
  • Table 139. Heart Disease Insurance: by Features(USD Million)
  • Table 140. Heart Disease Insurance Diagnosis/Procedure , by Region USD Million (2021-2026)
  • Table 141. Heart Disease Insurance Medicines Coverage , by Region USD Million (2021-2026)
  • Table 142. Heart Disease Insurance Surgery Coverage , by Region USD Million (2021-2026)
  • Table 143. Heart Disease Insurance Others , by Region USD Million (2021-2026)
  • Table 144. Heart Disease Insurance: by End User(USD Million)
  • Table 145. Heart Disease Insurance Children , by Region USD Million (2021-2026)
  • Table 146. Heart Disease Insurance Adult , by Region USD Million (2021-2026)
  • Table 147. South America Heart Disease Insurance, by Country USD Million (2021-2026)
  • Table 148. South America Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 149. South America Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 150. South America Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 151. South America Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 152. Brazil Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 153. Brazil Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 154. Brazil Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 155. Brazil Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 156. Argentina Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 157. Argentina Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 158. Argentina Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 159. Argentina Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 160. Rest of South America Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 161. Rest of South America Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 162. Rest of South America Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 163. Rest of South America Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 164. Asia Pacific Heart Disease Insurance, by Country USD Million (2021-2026)
  • Table 165. Asia Pacific Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 166. Asia Pacific Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 167. Asia Pacific Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 168. Asia Pacific Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 169. China Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 170. China Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 171. China Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 172. China Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 173. Japan Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 174. Japan Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 175. Japan Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 176. Japan Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 177. India Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 178. India Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 179. India Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 180. India Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 181. South Korea Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 182. South Korea Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 183. South Korea Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 184. South Korea Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 185. Taiwan Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 186. Taiwan Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 187. Taiwan Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 188. Taiwan Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 189. Australia Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 190. Australia Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 191. Australia Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 192. Australia Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 193. Rest of Asia-Pacific Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 194. Rest of Asia-Pacific Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 195. Rest of Asia-Pacific Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 196. Rest of Asia-Pacific Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 197. Europe Heart Disease Insurance, by Country USD Million (2021-2026)
  • Table 198. Europe Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 199. Europe Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 200. Europe Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 201. Europe Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 202. Germany Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 203. Germany Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 204. Germany Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 205. Germany Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 206. France Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 207. France Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 208. France Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 209. France Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 210. Italy Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 211. Italy Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 212. Italy Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 213. Italy Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 214. United Kingdom Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 215. United Kingdom Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 216. United Kingdom Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 217. United Kingdom Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 218. Netherlands Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 219. Netherlands Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 220. Netherlands Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 221. Netherlands Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 222. Rest of Europe Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 223. Rest of Europe Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 224. Rest of Europe Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 225. Rest of Europe Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 226. MEA Heart Disease Insurance, by Country USD Million (2021-2026)
  • Table 227. MEA Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 228. MEA Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 229. MEA Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 230. MEA Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 231. Middle East Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 232. Middle East Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 233. Middle East Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 234. Middle East Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 235. Africa Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 236. Africa Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 237. Africa Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 238. Africa Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 239. North America Heart Disease Insurance, by Country USD Million (2021-2026)
  • Table 240. North America Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 241. North America Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 242. North America Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 243. North America Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 244. United States Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 245. United States Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 246. United States Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 247. United States Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 248. Canada Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 249. Canada Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 250. Canada Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 251. Canada Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 252. Mexico Heart Disease Insurance, by Distribution Channel USD Million (2021-2026)
  • Table 253. Mexico Heart Disease Insurance, by Duration USD Million (2021-2026)
  • Table 254. Mexico Heart Disease Insurance, by Features USD Million (2021-2026)
  • Table 255. Mexico Heart Disease Insurance, by End User USD Million (2021-2026)
  • Table 256. Research Programs/Design for This Report
  • Table 257. Key Data Information from Secondary Sources
  • Table 258. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Heart Disease Insurance: by Distribution Channel USD Million (2015-2020)
  • Figure 5. Global Heart Disease Insurance: by Duration USD Million (2015-2020)
  • Figure 6. Global Heart Disease Insurance: by Features USD Million (2015-2020)
  • Figure 7. Global Heart Disease Insurance: by End User USD Million (2015-2020)
  • Figure 8. South America Heart Disease Insurance Share (%), by Country
  • Figure 9. Asia Pacific Heart Disease Insurance Share (%), by Country
  • Figure 10. Europe Heart Disease Insurance Share (%), by Country
  • Figure 11. MEA Heart Disease Insurance Share (%), by Country
  • Figure 12. North America Heart Disease Insurance Share (%), by Country
  • Figure 13. Global Heart Disease Insurance share by Players 2020 (%)
  • Figure 14. Global Heart Disease Insurance share by Players (Top 3) 2020(%)
  • Figure 15. Global Heart Disease Insurance share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Aviva plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. Aviva plc (United Kingdom) Revenue: by Geography 2020
  • Figure 19. Legal & General Group plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. Legal & General Group plc (United Kingdom) Revenue: by Geography 2020
  • Figure 21. Aflac Inc (United States) Revenue, Net Income and Gross profit
  • Figure 22. Aflac Inc (United States) Revenue: by Geography 2020
  • Figure 23. Axa S.A. (France) Revenue, Net Income and Gross profit
  • Figure 24. Axa S.A. (France) Revenue: by Geography 2020
  • Figure 25. Aegon Life Insurance (India) Revenue, Net Income and Gross profit
  • Figure 26. Aegon Life Insurance (India) Revenue: by Geography 2020
  • Figure 27. Allianz SE (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Allianz SE (Germany) Revenue: by Geography 2020
  • Figure 29. Gobeille v. Liberty Mutual Insurance (United States) Revenue, Net Income and Gross profit
  • Figure 30. Gobeille v. Liberty Mutual Insurance (United States) Revenue: by Geography 2020
  • Figure 31. MetLife, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. MetLife, Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Star Health Insurance (India) Revenue, Net Income and Gross profit
  • Figure 34. Star Health Insurance (India) Revenue: by Geography 2020
  • Figure 35. Global Heart Disease Insurance: by Distribution Channel USD Million (2021-2026)
  • Figure 36. Global Heart Disease Insurance: by Duration USD Million (2021-2026)
  • Figure 37. Global Heart Disease Insurance: by Features USD Million (2021-2026)
  • Figure 38. Global Heart Disease Insurance: by End User USD Million (2021-2026)
  • Figure 39. South America Heart Disease Insurance Share (%), by Country
  • Figure 40. Asia Pacific Heart Disease Insurance Share (%), by Country
  • Figure 41. Europe Heart Disease Insurance Share (%), by Country
  • Figure 42. MEA Heart Disease Insurance Share (%), by Country
  • Figure 43. North America Heart Disease Insurance Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Aviva plc (United Kingdom)
  • Legal & General Group plc (United Kingdom)
  • Aflac Inc (United States)
  • Axa S.A. (France)
  • Aegon Life Insurance (India)
  • Allianz SE (Germany)
  • Gobeille v. Liberty Mutual Insurance (United States)
  • MetLife, Inc. (United States)
  • Star Health Insurance (India)
Select User Access Type

Key Highlights of Report


Jan 2021 200 Pages 95 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Growing Number of Heart Disease Patients " is seen as one of major growth factors of Heart Disease Insurance Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Know More About Global Heart Disease Insurance Report?